Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Adline Chem Lab Ltd.

ADLINE.BO•BSE
Healthcare
Medical - Pharmaceuticals
₹14.02
₹-0.73(-4.95%)
Indian Market opens in 6h 43m

Adline Chem Lab Ltd. Fundamental Analysis

Adline Chem Lab Ltd. (ADLINE.BO) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.
We analyze ADLINE.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
0.0/100

We analyze ADLINE.BO's fundamental strength across five key dimensions:

Efficiency Score

Weak

ADLINE.BO struggles to generate sufficient returns from assets.

ROA > 10%
N/A

Valuation Score

Weak

ADLINE.BO trades at a premium to fair value.

PE < 25
N/A
PEG Ratio < 2
N/A

Growth Score

Weak

ADLINE.BO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

ADLINE.BO carries high financial risk with limited liquidity.

Debt/Equity < 1
N/A
Current Ratio > 1
N/A

Profitability Score

Weak

ADLINE.BO struggles to sustain strong margins.

ROE > 15%
N/A
Net Margin ≥ 15%
N/A
Positive Free Cash Flow
N/A

Key Financial Metrics

Is ADLINE.BO Expensive or Cheap?

No data available.

How Well Does ADLINE.BO Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How ADLINE.BO Stacks Against Its Sector Peers

MetricADLINE.BO ValueSector AveragePerformance
P/E RatioN/A29.45 N/A
ROEN/A779.00% N/A
Net MarginN/A-24936.00% (disorted) N/A
Debt/EquityN/A0.26 N/A
Current RatioN/A4.65 N/A
ROAN/A-19344.00% (disorted) N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Adline Chem Lab Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ